Loading
Journal of AIDS and HIV Treatment
ISSN: 2688-7436
Volume 3, Issue 1, p1-20
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Pre-exposure Prophylaxis (PrEP) for HIV Infection and New Sexually Transmitted Infections: A Win-Win Opportunity?
Pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition in patients exposed to a high risk of infection such as men who have sex with men (MSM), heterosexual couples, and people who inject drugs.
J AIDS HIV Treat, 2021, Volume 3, Issue 1, p1-3 | DOI: 10.33696/AIDS.3.011From Silos to Solidarity: Case Study of a Patient-Centered, Integrative Approach to Opioid Tapering and Chronic Pain Mitigation in a Multidisciplinary AIDS Clinic
Chronic pain, defined as pain lasting longer than three months, is a significant public health burden and has been associated with depression, anxiety, poor quality of life and opioid use disorder (OUD).
J AIDS HIV Treat, 2021, Volume 3, Issue 1, p4-11 | DOI: 10.33696/AIDS.3.012Remembering David Katzenstein (1952-2021)
I first met David shortly after arriving to work in Zimbabwe in 2015. He became a colleague and friend and we continued to collaborate, after my return to the UK in 2019, and indeed until his death in Harare, Zimbabwe, from the consequences of Covid-19 infection, on January 24th, 2021, with several manuscripts of this very productive collaboration, currently still in press.
J AIDS HIV Treat, 2021, Volume 3, Issue 1, p3-12 | DOI: 10.33696/AIDS.3.013HIV RNA Load and Antiretroviral Drug Resistance of HIV-1 Strains in Chad on Dried Blood Spots: A Pilot Study
In low-income Sub-Saharan Africa countries, peripheral blood HIV RNA levels monitoring twice a year in antiretroviral (ARV) drugs treated patient is a major WHO recommendation since 2013.
J AIDS HIV Treat, 2021, Volume 3, Issue 1, p13-16 | DOI: 10.33696/AIDS.3.014Dihydropteroate Synthase (DHPS) Gene Mutations in Human Pneumocystosis
Extraordinary journey began on June 18, 1981, the Centre for Disease Control and Prevention (CDC) in United States reported a cluster of Pneumocystis carinii pneumonia (now known as Pneumocystis jirovecii (P. jirovecii) pneumonia or Pneumocystis pneumonia in five gay men in Los Angeles.
J AIDS HIV Treat, 2021, Volume 3, Issue 1, p17-20 | DOI: 10.33696/AIDS.3.015Assessment of Attitudes toward HIV and AIDS among Undergraduate Students at a Historically Black University
HIV is no longer only a public health challenge, but also a global threat with a devastating negative impact that has claimed over 35 million lives globally. In 2017, about 36.9 million people live with HIV, and 1.8 million people becoming newly infected with the disease globally [1].
HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia
For more than 35 years, the world has grappled with an AIDS epidemic that has claimed an estimated 35.0 million [28.9 million-41.5 million] lives and at its peak threatened global stability and security.
Black Women's Contribution to the HIV/AIDS Fight
After thousands of years of gender conflicts, the world now stands at the beginning of the feminine era, when women will rise to their proper standing, and the entire world will experience the harmony between men and women.
AIDS Related Histoplasmosis, Treatment and Prophylaxis: the Mycology Unit of FJ Muniz Hospital Experience
Classic histoplasmosis is a systemic endemic mycosis due to the dimorphic fungus Histoplasma capsulatum var. capsulatum. This microorganism lives as mold in rich nitrogen soil in temperate and humid regions.
From Silos to Solidarity: Case Study of a Patient-Centered, Integrative Approach to Opioid Tapering and Chronic Pain Mitigation in a Multidisciplinary AIDS Clinic
Chronic pain, defined as pain lasting longer than three months, is a significant public health burden and has been associated with depression, anxiety, poor quality of life and opioid use disorder (OUD).
HIV RNA Load and Antiretroviral Drug Resistance of HIV-1 Strains in Chad on Dried Blood Spots: A Pilot Study
In low-income Sub-Saharan Africa countries, peripheral blood HIV RNA levels monitoring twice a year in antiretroviral (ARV) drugs treated patient is a major WHO recommendation since 2013.
Toward Personalized Medicine for HIV/AIDS
In 2019, approximately 38 million people were infected with HIV worldwide [1]. Although there is still no cure that successfully eradicates the disease, combination antiretroviral therapy (cART) has improved to a point where undetectable viral loads have become achievable and HIV carriers often live almost normal lives with very substantially increased average life expectancies compared to historical data.
High Levels of Pre-Treatment HIV Drug Resistance in Zimbabwe: Is this a Threat to HIV/AIDS Control?
Zimbabwe is one of the countries in Southern Africa most affected by the Human Immunodeficiency Virus (HIV) epidemic. The country has the third highest HIV prevalence (12.5% among 15-49 years) in the region, with an estimated 1.4 million people living with HIV (PLHIV) to date.
Painful to Discuss: The Intersection of Chronic Pain, Mental Health, and Analgesic Use among People with HIV
This retrospective chart review study aims to identify patients in an HIV clinical setting in an area of high HIV prevalence in Atlanta, Georgia, USA who have chronic pain, analgesic prescriptions, and/or mental health diagnoses.
HIV/AIDS Care and Support Services Satisfaction for Orphan and Vulnerable Children in Northwest Ethiopia: Mixed Method Study
Background: The provision of comprehensive care and support services to orphans and disadvantaged children that are individualized and tailored through the use of child- and family-centered information is critical but little if any information is available on satisfaction with HIV/AIDS care among orphans and vulnerable children in Gondar. Therefore, this study aimed to assess the satisfaction of HIV/AIDS care and support service delivered to caregivers of Orphans and Vulnerable Children, Gondar City, 2023.
Acute and Chronic Pain Management of the Urologic Patient
Objectives: Here, we review opioid-sparing or opioid-free anesthesia and pain management for urologic procedures and pathologies–urological pain syndromes, kidney stone pain management, development of post-surgical pain syndromes, and prevention. We explore acute management of perioperative pain during and after urologic procedures; additionally, we review the pathophysiology of various urologic pain syndromes along with a variety of interventions, including pharmacologic management, nerve blocks, neurolysis, and neuromodulatory therapies in hopes of educating providers who treat the urologic patient.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.